These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2643240)

  • 1. [Prostaglandin analogues in the treatment of peptic ulcer disease].
    Laursen LS; Havelund T; Lauritsen K; Madsen JR
    Ugeskr Laeger; 1989 Jan; 151(2):74-8. PubMed ID: 2643240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy and prevention of peptic lesions by prostaglandins].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins.
    Lauritsen K; Laursen LS; Rask-Madsen J
    Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and peptic ulcer therapy.
    Walt RP
    Scand J Gastroenterol Suppl; 1990; 174():29-36. PubMed ID: 1976271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins in clinical treatment of gastroduodenal mucosal lesions: a review.
    Aly A
    Scand J Gastroenterol Suppl; 1987; 137():43-9. PubMed ID: 3321405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.
    Goa KL; Monk JP
    Drugs; 1987 Nov; 34(5):539-59. PubMed ID: 3121276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins for duodenal ulcer.
    Lam SK
    Clin Invest Med; 1987 May; 10(3):232-7. PubMed ID: 2887323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
    J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin treatment for peptic ulcer.
    Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():40-9. PubMed ID: 2906468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [H2 receptor antagonists in the therapy of peptic ulcer disease].
    Dammann HG; Dau B; Dreyer M; Müller P; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():136-45. PubMed ID: 2889298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rioprostil: a new prostaglandin for treatment of peptic ulcer disease and NSAID-induced digestive lesions. Proceedings of an international symposium. Wiesbaden, 11-13 June 1987.
    Scand J Gastroenterol Suppl; 1989; 164():1-253. PubMed ID: 2510250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.